Saarländische Wagnisfinanzierungsgesellschaft mbh and KfW ERP-Startfonds have acquired a silent partnership in RedFlag Diagnostics GmbH, Homburg. Network Corporate Finance exclusively advised RedFlag Diagnostics GmbH on this transaction.
The funds will primarily be used for the market launch of new diagnostic tests for the detection of infectious diseases.
The Company is located at the campus of Homburg University Medical Centre and holds the rights and the patent of immunologically monitoring of T Cells in whole blood. This underlying diagnostic platform allows rapid, reliable diagnosis of complex infections like Mycobacterium Tuberculosis (TB) or Cytomegalovirus (CMV) by determining the immune status. Additional diagnostic tests complement company´s product range in the field of influenza as well as organ transplantation for the detection of alloreactive T Cells.